Products & Services
Applications

Applications

Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins.

Learn about applications
View all Applications
Resources
News Explore
Contact

Funding rounds

The Company has raised £613 million to date in the following fundraising rounds, and is currently well funded for the next phase of corporate development. The Company does not have traditional Venture Capital investment; instead, the investor profile more closely mirrors those of publicly listed companies.

  • Seed funding was obtained in two rounds, from IP Group in 2005.
  • In June 2006 the company raised £7.75m
  • In March 2008 the company raised a further £10m.
  • In January 2009 the Company announced an $18m (£11.9m) and a separate £2.1m investment
  • In February 2010 Oxford Nanopore raised £17.4m from existing investors and new, undisclosed US-based investors.
  • In April 2011 the Company raised £25m from existing and new institutional and independent investors based in the UK and US.
  • In May 2012 the Company raised £31.4m ($50.8m), the majority of which was from existing investors.
  • In October 2013 Oxford Nanopore raised £40m from new and existing investors in the US and Europe.
  • In August 2014 Oxford Nanopore raised £35m from new and existing investors in the US and Europe.
  • In July 2015 Oxford Nanopore raised £70m from new and existing investors in the US and Europe.
  • In December 2016 Oxford Nanopore raised £100m from new and existing investors worldwide.
  • In March 2018 Oxford Nanopore raised £100M ($140M) from global investors
  • In 2020 Oxford Nanopore announced that it had raised £29M + £49.4M +£84.4M in new capital in three tranches

 

Questions

We are not currently actively seeking investment, however if you have a general question please get in touch , please use our contact form.

Open a chat to talk to our sales team
FAQs

FAQs

Search